FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$27.31 B | $27.28 B | $27.12 B | $28.75 B | $29.44 B | $29.73 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$6.60 B | $5.66 B | $6.50 B | $6.25 B | $3.92 B | $6.14 B |
Gross Profit Revenue minus cost of revenue. |
|
$20.70 B | $21.62 B | $20.62 B | $22.50 B | $25.52 B | $23.60 B |
|
Operating Expense
Costs to run business. 
|
|
$10.79 B | $14.29 B | $13.01 B | $20.84 B | $13.71 B | $12.22 B |
Operating Income Profit from operations. |
|
$9.92 B | $7.33 B | $7.61 B | $1.66 B | $11.82 B | $11.38 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$1.00 B | -$829.00 M | -$568.00 M | -$696.00 M | -$1.02 B | -$749.00 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
$639.00 M | $581.00 M | -$198.00 M | -$5.00 M | $997.00 M | $111.00 M |
Total Other Income (Net) Net non-operating items. |
|
-$1.64 B | -$1.52 B | -$746.00 M | -$972.00 M | -$2.02 B | -$647.00 M |
Income Before Tax Profit before taxes. |
|
$8.28 B | $5.81 B | $6.86 B | $690.00 M | $9.80 B | $10.73 B |
Income Tax Expense Taxes on income. |
|
$2.08 B | $1.25 B | $1.25 B | $211.00 M | $1.29 B | $1.51 B |
|
Net Income
Final profit.
|
|
$6.23 B | $4.59 B | $5.67 B | $480.00 M | $8.51 B | $9.22 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$4.96 | $3.66 | $4.54 | $0.38 | $6.84 | $7.42 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$4.93 | $3.64 | $4.50 | $0.38 | $6.78 | $7.34 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
1.26 B | 1.26 B | 1.25 B | 1.25 B | 1.24 B | 1.24 B |
Diluted Average Shares Outst. Shares including dilution. |
|
1.26 B | 1.26 B | 1.26 B | 1.26 B | 1.26 B | 1.25 B |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$9.28 B | $6.75 B | $7.80 B | $1.67 B | $10.82 B | $11.26 B |
EBITDA Earnings before interest, tax, D&A. |
|
$11.33 B | $8.85 B | $10.50 B | $4.43 B | $10.82 B | $13.33 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$2.05 B | $2.10 B | $2.69 B | $2.77 B | - | $2.06 B |
| Company Report |
FY 2025
Gilead Sciences's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
Gilead Sciences's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
Gilead Sciences's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
Gilead Sciences's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
